These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 17507833
1. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Shifren JL, Desindes S, McIlwain M, Doros G, Mazer NA. Menopause; 2007; 14(6):985-94. PubMed ID: 17507833 [Abstract] [Full Text] [Related]
2. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA. J Clin Endocrinol Metab; 2008 May; 93(5):1702-10. PubMed ID: 18303079 [Abstract] [Full Text] [Related]
3. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. Taner MZ, Ozpolat E, Taskiran C, Onan MA, Gursel T, Karabulut E, Gursoy R, Himmetoglu O. Maturitas; 2006 Feb 20; 53(3):267-73. PubMed ID: 15978753 [Abstract] [Full Text] [Related]
9. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U. Clin Cancer Res; 2004 Jul 01; 10(13):4389-97. PubMed ID: 15240527 [Abstract] [Full Text] [Related]
10. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR. Gynecol Endocrinol; 2005 Mar 01; 20(3):144-9. PubMed ID: 16019353 [Abstract] [Full Text] [Related]
11. Transdermal progesterone cream as an alternative progestin in hormone therapy. Leonetti HB, Landes J, Steinberg D, Anasti JN. Altern Ther Health Med; 2005 Mar 01; 11(6):36-8. PubMed ID: 16320858 [Abstract] [Full Text] [Related]
12. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Qureshi AC, Bahri A, Breen LA, Barnes SC, Powrie JK, Thomas SM, Carroll PV. Clin Endocrinol (Oxf); 2007 May 01; 66(5):632-5. PubMed ID: 17492949 [Abstract] [Full Text] [Related]
13. Biologic effects of transdermal estradiol. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL. N Engl J Med; 1986 Jun 19; 314(25):1615-20. PubMed ID: 3012339 [Abstract] [Full Text] [Related]
14. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study. Sendağ F, Terek MC, Karadadaş N, Bilgin O. J Reprod Med; 2001 Nov 19; 46(11):962-8. PubMed ID: 11762152 [Abstract] [Full Text] [Related]
15. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Santoro N, Allshouse A, Neal-Perry G, Pal L, Lobo RA, Naftolin F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Dunn M, Gleason CE, Hodis HN, Isaac B, Magnani M, Manson JE, Miller VM, Taylor HS, Wharton W, Wolff E, Zepeda V, Harman SM. Menopause; 2017 Mar 19; 24(3):238-246. PubMed ID: 27779568 [Abstract] [Full Text] [Related]
16. Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. Erel CT, Gezer A, Sentürk LM, Somunkiran A, Kaleli S, Seyisoglu H. J Reprod Med; 2007 Dec 19; 52(12):1079-84. PubMed ID: 18210897 [Abstract] [Full Text] [Related]
17. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin. Odmark IS, Carlström K, Jonsson B, Jonasson AF. Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160 [Abstract] [Full Text] [Related]
18. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Climacteric; 2002 Dec 10; 5(4):357-65. PubMed ID: 12626215 [Abstract] [Full Text] [Related]
19. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M, Fait T, Kovar J, Poledne R, Ceska R. Metabolism; 2008 Aug 10; 57(8):1088-92. PubMed ID: 18640386 [Abstract] [Full Text] [Related]
20. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Mueck AO, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H. Menopause; 2007 Aug 10; 14(6):978-84. PubMed ID: 17595593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]